CRP and thrombocytosis disease: In COVID-19 patients receiving prophylactic anticoagulation, elevated levels of C-reactive protein (OR 2.7) and D-dimer (OR 6.7), as well as thrombocytosis (OR 3.5) at admission were predictive of coagulation-associated complications during hospitalization [37].